To fully investigate the efficacy and safety of bevacizumab for glioblastoma. Databases were searched for phase II/III randomized controlled trials treated with bevacizumab. Bevacizumab significantly
Introduction: Recent years have seen rapid growth in cancer treatments that enhance the anti-tumor activities of the immune system. Collectively known as immunotherapy, modulation of the immune system
The potential therapeutic benefit of fluoxetine with standard of care treatment was evaluated in GBM patients cohort using electronic medical records from the IBM MarketScan Dataset (2003-2017). GBM P
